1 |
Tao, R., Coleman, M. C., Pennington, J. D., Ozden, O., Park, S. H., Jiang, H., Kim, H. S., Flynn, C. R., Hill, S., Hayes McDonald, W., Olivier, A. K., Spitz, D. R. and Gius, D. (2010) Sirt3-mediated deacetylation of evolutionarily conserved lysine 122 regulates MnSOD activity in response to stress. Mol. Cell 40, 893-904.
DOI
ScienceOn
|
2 |
Chen, Y., Zhang, J., Lin, Y., Lei, Q., Guan, K. L., Zhao, S. and Xiong, Y. (2011) Tumour suppressor SIRT3 deacetylates and activates manganese superoxide dismutase to scavenge ROS. EMBO Rep. 12, 534-541.
DOI
ScienceOn
|
3 |
Finley, L. W., Carracedo, A., Lee, J., Souza, A., Egia, A., Zhang, J., Teruya-Feldstein, J., Moreira, P. I., Cardoso, S. M., Clish, C. B., Pandolfi, P. P. and Haigis, M. C. (2011) SIRT3 opposes reprogramming of cancer cell metabolism through HIF1 destabilization. Cancer Cell 19, 416-428.
DOI
ScienceOn
|
4 |
Inuzuka, H., Gao, D., Finley, L. W., Yang, W., Wan, L., Fukushima, H., Chin, Y. R., Zhai, B., Shaik, S., Lau, A. W., Wang, Z., Gygi, S. P., Nakayama, K., Teruya-Feldstein, J., Toker, A., Haigis, M. C., Pandolfi, P. P. and Wei, W. (2012) Acetylation-dependent regulation of Skp2 function. Cell 50, 179-193.
|
5 |
Finley, L. W. and Haigis, M. C. (2012) Metabolic regulation by SIRT3: implications for tumorigenesis. Trends Mol. Med. 18, 516-523.
DOI
ScienceOn
|
6 |
Haigis, M. C., Mostoslavsky, R., Haigis, K. M., Fahie, K., Christodoulou, D. C., Murphy, A. J., Valenzuela, D. M., Yancopoulos, G. D., Karow, M., Blander, G., Wolberger, C., Prolla, T. A., Weindruch, R., Alt, F. W. and Guarente, L. (2006) SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic beta cells. Cell 126, 941-954.
DOI
ScienceOn
|
7 |
Laurent, G., German, N. J., Saha, A. K., de Boer, V. C., Davies, M., Koves, T. R., Dephoure, N., Fischer, F., Boanca, G., Vaitheesvaran, B., Lovitch, S. B., Sharpe, A. H., Kurland, I. J., Steegborn, C., Gygi, S. P., Muoio, D. M., Ruderman, N. B. and Haigis, M. C. (2013) SIRT4 Coordinates the Balance between Lipid Synthesis and Catabolism by Repressing Malonyl CoA Decarboxylase. Mol. Cell 50, 686-698.
DOI
ScienceOn
|
8 |
Nasrin, N., Wu, X., Fortier, E., Feng, Y., Bare', O. C., Chen, S., Ren, X., Wu, Z., Streeper, R. S. and Bordone, L. (2010) SIRT4 regulates fatty acid oxidation and mitochondrial gene expression in liver and muscle cells. J. Biol. Chem. 285, 31995-32002.
DOI
ScienceOn
|
9 |
Ahn, B. H., Kim, H. S., Song, S., Lee, I. H., Liu, J., Vassilopoulos, A., Deng, C. X. and Finkel, T. (2008) A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis. Proc. Natl. Acad. Sci. U. S. A. 105, 14447-14452.
DOI
ScienceOn
|
10 |
Hirschey, M. D., Shimazu, T., Goetzman, E., Jing, E., Schwer, B., Lombard, D. B., Grueter, C. A., Harris, C., Biddinger, S., Ilkayeva, O. R., Stevens, R. D., Li, Y., Saha, A. K., Ruderman, N. B., Bain, J. R., Newgard, C. B., Farese, R. V. Jr., Alt, F. W., Kahn, C. R. and Verdin, E. (2010) SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature 464, 121-125.
DOI
ScienceOn
|
11 |
Kong, X., Wang, R., Xue, Y., Liu, X., Zhang, H., Chen, Y., Fang, F. and Chang, Y. (2010) Sirtuin 3, a new target of PGC-1alpha, plays an important role in the suppression of ROS and mitochondrial biogenesis. PLoS One 5, e11707.
DOI
ScienceOn
|
12 |
Kim, H. S., Patel, K., Muldoon-Jacobs, K., Bisht, K. S., Aykin-Burns, N., Pennington, J. D., van der Meer, R., Nguyen, P., Savage, J., Owens, K. M., Vassilopoulos, A., Ozden, O., Park, S. H., Singh, K. K., Abdulkadir, S. A., Spitz, D. R., Deng, C. X. and Gius, D. (2010) SIRT3 is a mitochondria-localized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during stress. Cancer Cell. 17, 41-52.
DOI
ScienceOn
|
13 |
Anderson, K. A. and Hirschey, M. D. (2012) Mitochondrial protein acetylation regulates metabolism. Essays Biochem. 52, 23-35.
DOI
|
14 |
Dan, L., Klimenkova, O., Klimiankou, M., Klusman, J. H., van den Heuvel-Eibrink, M. M., Reinhardt, D., Welte, K. and Skokowa, J. (2012) The role of sirtuin 2 activation by nicotinamide phosphoribosyltransferase in the aberrant proliferation and survival of myeloid leukemia cells. Haematologica. 97, 551-559.
DOI
|
15 |
Someya, S., Yu, W., Hallows, W. C., Xu, J., Vann, J. M., Leeuwenburgh, C., Tanokura, M., Denu, J. M. and Prolla, T. A. (2010) Sirt3 mediates reduction of oxidative damage and prevention of age-related hearing loss under caloric restriction. Cell 143, 802-812.
DOI
ScienceOn
|
16 |
Hebert, A. S., Dittenhafer-Reed, K. E., Yu, W., Bailey, D. J., Selen, E. S., Boersma, M. D., Carson, J. J., Tonelli, M., Balloon, A. J., Higbee, A. J., Westphall, M. S., Pagliarini, D. J., Prolla, T. A., Assadi-Porter, F., Roy, S., Denu, J. M. and Coon, J. J. (2013) Calorie restriction and SIRT3 trigger global reprogramming of the mitochondrial protein acetylome. Mol. Cell 49, 186-199.
|
17 |
Ong, C. A., Shapiro, J., Nason, K. S., Davison, J. M., Liu, X., Ross-Innes, C., O'Donovan, M., Dinjens, W. N., Biermann, K., Shannon, N., Worster, S., Schulz, L. K., Luketich, J. D., Wijnhoven, B. P., Hardwick, R. H. and Fitzgerald, R. C. (2013) Three-gene immunohistochemical panel adds to clinical staging algorithms to predict prognosis for patients with esophageal adenocarcinoma. J. Clin. Oncol. 31, 1576-1582.
DOI
ScienceOn
|
18 |
Liu, P. Y., Xu, N., Malyukova, A., Scarlett, C. J., Sun, Y. T., Zhang, X. D., Ling, D., Su, S. P., Nelson, C., Chang, D. K., Koach, J., Tee, A. E., Haber, M., Norris, M. D., Toon, C., Rooman, I., Xue, C., Cheung, B. B., Kumar, S., Marshall, G. M., Biankin, A. V. and Liu, T. (2013) The histone deacetylase SIRT2 stabilizes Myc oncoproteins. Cell Death Differ. 20, 503-514.
DOI
ScienceOn
|
19 |
Chen, J., Chan, A. W., To, K. F., Chen, W., Zhang, Z., Ren, J., Song, C., Cheung, Y. S., Lai, P. B., Cheng, S. H., Ng, M. H., Huang, A. and Ko, B. C. (2013) SIRT2 overexpression in hepatocellular carcinoma mediates epithelial to mesenchymal transition by protein kinase B/glycogen synthase kinase-/-catenin signaling. Hepatology 57, 2287-2298.
DOI
ScienceOn
|
20 |
Yang, M. H., Laurent, G., Bause, A. S., Spang, R., German, N., Haigis, M. C. and Haigis, K. M. (2013) HDAC6 and SIRT2 regulate the acetylation state and oncogenic activity of mutant K-RAS. Mol. Cancer Res. [Epub ahead of print].
|
21 |
Huang, J. Y., Hirschey, M. D., Shimazu, T., Ho, L. and Verdin, E. (2010) Mitochondrial sirtuins. Biochim. Biophys. Acta. 1804, 1645-1651.
DOI
ScienceOn
|
22 |
Kim, S. C., Sprung, R., Chen, Y., Xu, Y., Ball, H., Pei, J., Cheng, T., Kho, Y., Xiao, H., Xiao, L., Grishin, N. V., White, M., Yang, X. J. and Zhao, Y. (2006) Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. Mol. Cell. 23, 607-618.
DOI
ScienceOn
|
23 |
Pandithage, R., Lilischkis, R., Harting, K., Wolf, A., Jedamzik, B., Luscher-Firzlaff, J., Vervoorts, J., Lasonder, E., Kremmer, E., Knoll, B. and Luscher, B. (2008) The regulation of SIRT2 function by cyclin-dependent kinases affects cell motility. J. Cell Biol. 180, 915-929.
DOI
ScienceOn
|
24 |
Donmez, G. and Outeiro, T. F. (2013) SIRT1 and SIRT2: emerging targets in neurodegeneration. EMBO Mol. Med. 5, 344-352.
DOI
|
25 |
Outeiro, T. F., Kontopoulos, E., Altmann, S. M., Kufareva, I., Strathearn, K. E., Amore, A. M., Volk, C. B., Maxwell, M. M., Rochet, J. C., McLean, P. J., Young, A. B., Abagyan, R., Feany, M. B., Hyman, B. T. and Kazantsev, A. G. (2007) Sirtuin 2 inhibitors rescue alpha-synuclein- mediated toxicity in models of Parkinson's disease. Science 317, 516-519.
DOI
ScienceOn
|
26 |
Narayan, N., Lee, I. H., Borenstein, R., Sun, J., Wong, R., Tong, G., Fergusson, M. M., Liu, J., Rovira, I. I., Cheng, H. L., Wang, G., Gucek, M., Lombard, D., Alt, F. , Sack, M. N., Murphy, E., Cao, L. and Finkel, T. (2013) The NAD-dependent deacetylase SIRT2 is required for programmed necrosis. Nature 492, 199-204.
|
27 |
Hiratsuka, M., Inoue, T., Toda, T., Kimura, N., Shirayoshi, Y., Kamitani, H., Watanabe, T., Ohama, E., Tahimic, C. G., Kurimasa, A. and Oshimura, M. (2003) Proteomicsbased identification of differentially expressed genes in human gliomas: down-regulation of SIRT2 gene. B BRC 309, 558-566.
|
28 |
Lai, C. C., Lin, P. M., Lin, S. F., Hsu, C. H., Lin, H. C., Hu, M. L., Hsu, C. M. and Yang, M. Y. (2013) Altered expression of SIRT gene family in head and neck squamous cell carcinoma. Tumour Biol. 34, 1847-1854.
DOI
ScienceOn
|
29 |
Inoue, T., Hiratsuka, M., Osaki, M., Yamada, H., Kishimoto, I., Yamaguchi, S., Nakano, S., Katoh, M., Ito, H. and Oshimura, M. (2007) SIRT2, a tubulin deacetylase, acts to block the entry to chromosome condensation in response to mitotic stress. Oncogene. 26, 945-957.
DOI
ScienceOn
|
30 |
Inoue, T., Hiratsuka, M., Osaki, M. and Oshimura, M. (2007) The molecular biology of mammalian SIRT proteins: SIRT2 in cell cycle regulation. Cell Cycle 6, 1011-1018.
DOI
ScienceOn
|
31 |
Serrano, L., Martinez-Redondo, P., Marazuela-Duque, A., Vazquez, B. N., Dooley, S. J., Voigt, P., Beck, D. B., Kane-Goldsmith, N., Tong, Q., Rabanal, R. M., Fondevila, D., Munoz, P., Kruger, M., Tischfield, J. A. and Vaquero, A. (2013) The tumor suppressor SirT2 regulates cell cycle progression and genome stability by modulating the mitotic deposition of H4K20 methylation. Genes Dev. 27, 639-653.
DOI
ScienceOn
|
32 |
Wilson, J. M., Le, V. Q., Zimmerman, C., Marmorstein, R. and Pillus, L. (2006) Nuclear export modulates the cytoplasmic Sir2 homologue Hst2. EMBO Rep. 7, 1247-1251.
DOI
ScienceOn
|
33 |
North, B. J., Marshall, B. L., Borra, M. T., Denu, J. M. and Verdin, E. (2003) The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase. Mol. Cell. 11, 437-444.
DOI
ScienceOn
|
34 |
Jing, E., Gesta, S. and Kahn, C. R. (2007) SIRT2 regulates adipocyte differentiation through FoxO1 acetylation/deacetylation. Cell Metab. 6, 105-114.
DOI
ScienceOn
|
35 |
Wang, F., Nguyen, M., Qin, F. X. and Tong, Q. (2007) SIRT2 deacetylates FOXO3a in response to oxidative stress and caloric restriction. Aging Cell. 6, 505-514.
DOI
ScienceOn
|
36 |
Jin, Y. H., Kim, Y. J., Kim, D. W., Baek, K. H., Kang, B. Y., Yeo, C. Y. and Lee, K. Y. (2008) Sirt2 interacts with 14-3-3 beta/gamma and down-regulates the activity of p53. Biochem. Biophys. Res. Commun. 368, 690-695.
DOI
ScienceOn
|
37 |
North, B. J. and Verdin, E. (2007) Mitotic regulation of SIRT2 by cyclin-dependent kinase 1-dependent phosphorylation. J. Biol. Chem. 282, 19546-19555.
DOI
ScienceOn
|
38 |
Kim, H. S., Vassilopoulos, A., Wang, R. H., Lahusen, T., Xiao, Z., Xu, X., Li, C., Veenstra, T. D., Li, B., Yu, H., Ji, J., Wang, X. W., Park, S. H., Cha, Y. I., Gius, D. and Deng, C. X. (2011) SIRT2 maintains genome integrity and suppresses tumorigenesis through regulating APC/C activity. Cancer Cell. 20, 487-499.
DOI
ScienceOn
|
39 |
Jiang, W., Wang, S., Xiao, M., Lin, Y., Zhou, L., Lei, Q., Xiong, Y., Guan, K. L. and Zhao, S. (2011) Acetylation regulates gluconeogenesis by promoting PEPCK1 degradation via recruiting the UBR5 ubiquitin ligase. Mol. Cell. 43, 33-44.
DOI
ScienceOn
|
40 |
Das, C., Lucia, M. S., Hansen, K. C. and Tyler, J. K. (2009) CBP/p300-mediated acetylation of histone H3 on lysine 56. Nature 459, 113-117.
DOI
ScienceOn
|
41 |
Baur, J. A., Ungvari, Z., Minor, R. K., Le Couteur, D. G. and de Cabo, R. (2012) Are sirtuins viable targets for improving healthspan and lifespan? Nat. Rev. Drug Discov. 11, 443-461.
DOI
ScienceOn
|
42 |
Haigis, M. C. and Sinclair, D. A. (2010) Mammalian sirtuins: biological insights and disease relevance. Annu. Rev. Pathol. 5, 253-295.
DOI
ScienceOn
|
43 |
Lee, S. H. and Min, K. J. (2013) Caloric restriction and its mimetics. BMB Rep. 46, 181-187.
과학기술학회마을
DOI
ScienceOn
|
44 |
Du, J., Zhou, Y., Su, X., Yu, J. J., Khan, S., Jiang, H., Kim, J., Woo, J., Kim, J. H., Choi, B. H., He, B., Chen, W., Zhang, S., Cerione, R. A., Auwerx, J., Hao, Q. and Lin, H. (2011) Sirt5 is a NAD-dependent protein lysine demalonylase and desuccinylase. Science 334, 806-809.
DOI
ScienceOn
|
45 |
Jiang, H., Khan, S., Wang, Y., Charron, G., He, B., Sebastian, C., Du, J., Kim, R., Ge, E., Mostoslavsky, R., Hang, H. C., Hao, Q. and Lin, H. (2013) SIRT6 regulates TNF- secretion through hydrolysis of long-chain fatty acyl lysine. Nature 496, 110-113.
DOI
ScienceOn
|
46 |
Hall, J. A., Dominy, J. E., Lee, Y. and Puigserver, P. (2013) The sirtuin family's role in aging and age-associated pathologies. J. Clin Invest. 123, 973-979.
DOI
ScienceOn
|
47 |
Roth, M. and Chen, W. Y. (2013) Sorting out functions of sirtuins in cancer. Oncogene. Apr 22. doi: 10.1038/onc. 2013.120. [Epub ahead of print].
DOI
ScienceOn
|
48 |
Morris, B. J. (2013) Seven sirtuins for seven deadly diseases of aging. Free Radic. Biol. Med. 56, 133-171.
DOI
ScienceOn
|
49 |
Martinez-Pastor, B. and Mostoslavsky, R. (2012) Sirtuins, metabolism, and cancer. Front Pharmacol. 2012;3:22. doi: 10.3389/fphar.2012.00022. Epub 2012 Feb 21.
DOI
ScienceOn
|
50 |
Dryden, S. C., Nahhas, F. A., Nowak, J. E., Goustin, A. S. and Tainsky, M. A. (2003) Role for human SIRT2 NAD-dependent deacetylase activity in control of mitotic exit in the cell cycle. Mol. Cell Biol. 23, 3173-3185.
DOI
ScienceOn
|
51 |
Moskalev, A. A., Shaposhnikov, M. V., Plyusnina, E. N., Zhavoronkov, A., Budovsky, A., Yanai, H. and Fraifeld, V. E. (2012) The role of DNA damage and repair in aging ugh the prism of Koch-like criteria. Ageing Res. Rev. 12, 661-684.
|
52 |
Hoeijmakers, J. H. (2009) DNA damage, aging, and cancer. N. Engl. J. Med. 361, 1475-1485.
DOI
ScienceOn
|
53 |
Blackburn, E. H., Greider, C. W. and Szostak, J. W. (2006) Telomeres and telomerase: the path from maize, Tetrahymena and yeast to human cancer and aging. Nat. Med. 12, 1133-1138.
DOI
ScienceOn
|
54 |
Fraga, M. F. and Esteller, M. (2007) Epigenetics and aging: the targets and the marks. Trends Genet. 23, 413-418.
DOI
ScienceOn
|
55 |
Powers, E. T., Morimoto, R. I., Dillin, A., Kelly, J. W. and Balch, W. E. (2009) Biological and chemical approaches to diseases of proteostasis deficiency. Annu. Rev. Biochem. 78, 959-991.
DOI
ScienceOn
|
56 |
Laplante, M. and Sabatini, D. M. (2012) mTOR signaling in growth control and disease. Cell. 149, 274-293.
DOI
ScienceOn
|
57 |
Green, D. R., Galluzzi, L. and Kroemer, G. (2011) Mitochondria and the autophagy-inflammation-cell death axis in organismal aging. Science 333, 1109-1112.
DOI
ScienceOn
|
58 |
Campisi, J. and d'Adda di Fagagna, F. (2007) Cellular senescence: when bad things happen to good cells. Nat. Rev. Mol. Cell Biol. 8, 729-740.
DOI
ScienceOn
|
59 |
Rossi, D. J., Bryder, D., Seita, J., Nussenzweig, A., Hoeijmakers, J. and Weissman, I. L. (2007) Deficiencies in DNA damage repair limit the function of haematopoietic stem cells with age. Nature 447, 725-729.
DOI
ScienceOn
|
60 |
Barzilai, N., Huffman, D. M., Muzumdar, R. H. and Bartke, A. (2012) The critical role of metabolic pathways in aging. Diabetes 61, 1315-1322.
DOI
|
61 |
Imai, S., Armstrong, C. M., Kaeberlein, M. and Guarente, L. (2000) Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 403, 795-800.
DOI
ScienceOn
|
62 |
Frye, R. A. (2000) Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins. Biochem. Biophys. Res. Commun. 273, 793-798.
DOI
ScienceOn
|
63 |
Park, J., Chen, Y., Tishkoff, D. X., Peng, C., Tan, M., Dai, L., Xie, Z., Zhang, Y., Zwaans, B. M., Skinner, M. E., Lombard, D. B. and Zhao, Y. (2013) SIRT5-Mediated Lysine Desuccinylation Impacts Diverse Metabolic Pathways. Mol. Cell 50, 919-930.
DOI
ScienceOn
|
64 |
Jia, G., Su, L., Singhal, S. and Liu, X. (2012) Emerging roles of SIRT6 on telomere maintenance, DNA repair, metabolism and mammalian aging. Mol. Cell Biochem. 364, 345-350.
DOI
ScienceOn
|
65 |
Jiang, H., Khan, S., Wang, Y., Charron, G., He, B., Sebastian, C., Du, J., Kim, R., Ge, E., Mostoslavsky, R., Hang, H. C., Hao, Q. and Lin, H. (2013) SIRT6 regulates TNF- secretion through hydrolysis of long-chain fatty acyl lysine. Nature 496, 110-113.
DOI
ScienceOn
|
66 |
Kaidi, A., Weinert, B. T., Choudhary, C. and Jackson, S. P. (2010) Human SIRT6 promotes DNA end resection through CtIP deacetylation. Science 329, 1348-1353.
DOI
ScienceOn
|
67 |
Mostoslavsky, R., Chua, K. F., Lombard, D. B., Pang, W. W., Fischer, M. R., Gellon, L., Liu, P., Mostoslavsky, G., Franco, S., Murphy, M. M., Mills, K. D., Patel, P., Hsu, J. T., Hong, A. L., Ford, E., Cheng, H. L., Kennedy, C., Nunez, N., Bronson, R., Frendewey, D., Auerbach, W., Valenzuela, D., Karow, M., Hottiger, M. O., Hursting, S., Barrett, J. C., Guarente, L., Mulligan, R., Demple, B., Yancopoulos, G. D. and Alt, F. W. (2006) Genomic instability and aging-like phenotype in the absence of mammalian SIRT6. Cell 124, 315-329.
DOI
ScienceOn
|
68 |
Michishita, E., McCord, R. A., Berber, E., Kioi, M., Padilla-Nash, H., Damian, M., Cheung, P., Kusumoto, R., Kawahara, T. L., Barrett, J. C., Chang, H. Y., Bohr, V. A., Ried, T., Gozani, O. and Chua, K. F. (2008) SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin. Nature 452, 492-496.
DOI
ScienceOn
|
69 |
Yang, B., Zwaans, B. M., Eckersdorff, M. and Lombard, D. B. (2009) The sirtuin SIRT6 deacetylates H3K56Ac in vivo to promote genomic stability. Cell Cycle. 8, 2662-2663.
DOI
|
70 |
Hanahan, D. and Weinberg, R. A. (2000) The hallmarks of cancer. Cell 100, 57-70.
DOI
ScienceOn
|
71 |
Lopez-Otin, C., Blasco, M. A., Partridge, L., Serrano, M. and Kroemer, G. (2013) The hallmarks of aging. Cell 153, 1194-1217.
DOI
ScienceOn
|
72 |
Hanahan, D. and Weinberg, R. A. (2011) Hallmarks of cancer: the next generation. Cell 144, 646-674.
DOI
ScienceOn
|
73 |
Khongkow, M., Olmos, Y., Gong, C., Gomes, A. R., Monteiro, L. J., Yague, E., Cavaco, T. B., Khongkow, P., Man, E. P., Laohasinnarong, S., Koo, C. Y., Harada-Shoji, N., Tsang, J. W., Coombes, R. C., Schwer, B., Khoo, U. S. and Lam, E. W. (2013) SIRT6 modulates paclitaxel and epirubicin resistance and survival in breast cancer. Carcinogenesis. 34, 1476-1486.
DOI
ScienceOn
|
74 |
Ford, E., Voit, R., Liszt, G., Magin, C., Grummt, I. and Guarente, L. (2006) Mammalian Sir2 homolog SIRT7 is an activator of RNA polymerase I transcription. Genes Dev. 20, 1075-1080.
DOI
ScienceOn
|
75 |
Jeong, S. M., Xiao, C., Finley, L. W., Lahusen, T., Souza, A. L., Pierce, K., Li, Y. H., Wang, X., Laurent, G., German, N. J., Xu, X., Li, C., Wang, R. H., Lee, J., Csibi, A., Cerione, R., Blenis, J., Clish, C. B., Kimmelman, A., Deng, C. X. and Haigis, M. C. (2013) SIRT4 has tumor-suppressive activity and regulates the cellular metabolic response to DNA damage by inhibiting mitochondrial glutamine metabolism. Cancer Cell 23, 450-463.
DOI
ScienceOn
|
76 |
Mao, Z., Hine, C., Tian, X., Van Meter, M., Au, M., Vaidya, A., Seluanov, A. and Gorbunova, V. (2011) SIRT6 promotes DNA repair under stress by activating PARP1. Science 332, 1443-1446.
DOI
ScienceOn
|
77 |
Zhong, L., D'Urso, A., Toiber, D., Sebastian, C., Henry, R. E., Vadysirisack, D. D., Guimaraes, A., Marinelli, B., Wikstrom, J. D., Nir, T., Clish, C. B., Vaitheesvaran, B., Iliopoulos, O., Kurland, I., Dor, Y., Weissleder, R., Shirihai, O. S., Ellisen, L. W., Espinosa, J. M. and Mostoslavsky, R. (2010) The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1alpha. Cell 140, 280-293
DOI
ScienceOn
|
78 |
Yang, H., Yang, T., Baur, J. A., Perez, E., Matsui, T., Carmona, J. J., Lamming, D. W., Souza-Pinto, N. C., Bohr, V. A., Rosenzweig, A., de Cabo, R., Sauve, A. A. and Sinclair, D. A. (2007) Nutrient-sensitive mitochondrial NAD+ levels dictate cell survival. Cell 130, 1095-1107.
DOI
ScienceOn
|
79 |
Du, J., Zhou, Y., Su, X., Yu, J. J., Khan, S., Jiang, H., Kim, J., Woo, J., Kim, J. H., Choi, B. H., He, B., Chen, W., Zhang, S., Cerione, R. A., Auwerx, J., Hao, Q. and Lin, H. (2011) Sirt5 is a NAD-dependent protein lysine demalonylase and desuccinylase. Science 334, 806-809.
DOI
ScienceOn
|
80 |
Nakagawa, T., Lomb, D. J., Haigis, M. C. and Guarente, L. (2009) SIRT5 Deacetylates carbamoyl phosphate synthetase 1 and regulates the urea cycle. Cell 137, 560-570.
DOI
ScienceOn
|
81 |
Kim, J. K., Noh, J. H., Jung, K. H., Eun, J. W., Bae, H. J., Kim, M. G., Chang, Y. G., Shen, Q., Park, W. S., Lee, J. Y., Borlak, J. and Nam, S. W. (2013) Sirtuin7 oncogenic potential in human hepatocellular carcinoma and its regulation by the tumor suppressors MiR-125a-5p and MiR-125b. Hepatology 57, 1055-1067.
DOI
ScienceOn
|
82 |
Sebastian, C., Zwaans, B. M., Silberman, D. M., Gymrek, M., Goren, A., Zhong, L., Ram, O., Truelove, J., Guimaraes, A. R., Toiber, D., Cosentino, C., Greenson, J. K., MacDonald, A. I., McGlynn, L., Maxwell, F., Edwards, J., Giacosa, S., Guccione, E., Weissleder, R., Bernstein, B. E., Regev, A., Shiels, P. G., Lombard, D. B. and Mostoslavsky, R. (2012) The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism. Cell 151, 1185-1199.
DOI
ScienceOn
|
83 |
Min, L., Ji, Y., Bakiri, L., Qiu, Z., Cen, J., Chen, X., Chen, L., Scheuch, H., Zheng, H., Qin, L., Zatloukal, K., Hui, L. and Wagner, E. F. (2012) Liver cancer initiation is controlled by AP-1 through SIRT6-dependent inhibition of survivin. Nat. Cell Biol. 14, 1203-1211.
DOI
ScienceOn
|
84 |
Xiao, C., Wang, R. H., Lahusen, T. J., Park, O., Bertola, A., Maruyama, T., Reynolds, D., Chen, Q., Xu, X., Young, H. A., Chen, W. J., Gao, B. and Deng, C. X. (2012) Progression of chronic liver inflammation and fibrosis driven by activation of c-JUN signaling in Sirt6 mutant mice. J. Biol. Chem. 287, 41903-41913.
DOI
|
85 |
Marquardt, J. U., Fischer, K., Baus, K., Kashyap, A., Ma, S., Krupp, M., Linke, M., Teufel, A., Zechner, U., Strand, D., Thorgeirsson, S. S., Galle, P. R. and Strand, S. (2013) SIRT6 dependent genetic and epigenetic alterations are associated with poor clinical outcome in HCC patients. Hepatology doi: 10.1002/hep.26413. [Epub ahead of print].
DOI
ScienceOn
|
86 |
Bauer, I., Grozio, A., Lasiglie, D., Basile, G., Sturla, L., Magnone, M., Sociali, G., Soncini, D., Caffa, I., Poggi, A., Zoppoli, G., Cea, M., Feldmann, G., Mostoslavsky, R., Ballestrero, A., Patrone, F., Bruzzone, S. and Nencioni, A. (2012) The NAD+-dependent histone deacetylase SIRT6 promotes cytokine production and migration in pancreatic cancer cells by regulating Ca2+ responses. J. Biol. Chem. 287, 40924-40937.
DOI
|
87 |
Vakhrusheva, O., Smolka, C., Gajawada, P., Kostin, S., Boettger, T., Kubin, T., Braun, T. and Bober, E. (2008) Sirt7 increases stress resistance of cardiomyocytes and prevents apoptosis and inflammatory cardiomyopathy in mice. Circ. Res. 102, 703-710.
DOI
ScienceOn
|
88 |
Barber, M. F., Michishita-Kioi, E., Xi, Y., Tasselli, L., Kioi, M., Moqtaderi, Z., Tennen, RI., Paredes, S., Young, N. L., Chen, K., Struhl, K., Garcia, B. A., Gozani, O., Li, W. and Chua, K. F. (2012) SIRT7 links H3K18 deacetylation to maintenance of oncogenic transformation. Nature 487, 114-118
|
89 |
Yoon, I. S., Chung, J. H., Hahm, S. H., Park, M. J., Lee, Y. R., Kang, L. W., Kim, T. S., Kim, J. and Han, Y. S. (2011) Ribosomal protein S3 is phosphorylated by Cdk1/cdc2 during G2/M phase. BMB Rep. 44, 529-534.
과학기술학회마을
DOI
ScienceOn
|